• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(ADP-核糖)聚合酶2是一种锌依赖性酶和核小体重组器。

Poly(ADP-ribose)polymerase 2 is zinc-dependent enzyme and nucleosome reorganizer.

作者信息

Maluchenko Natalya, Saulina Alexandra, Geraskina Olga, Kotova Elena, Korovina Anna, Armeev Grigoriy, Kirpichnikov Mikhail, Feofanov Alexey, Studitsky Vasily

机构信息

Faculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia.

出版信息

Cell Mol Life Sci. 2025 Jun 30;82(1):267. doi: 10.1007/s00018-025-05785-8.

DOI:10.1007/s00018-025-05785-8
PMID:40586906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12209172/
Abstract

Poly(ADP-ribose)polymerase 2 (PARP2) is a nuclear protein, DNA damage sensor and an emerging target for development of anti-cancer drugs. Previously it was discovered that PARP2 binds to nucleosomes; however, critical factors involved in this process remain unknown. We demonstrated that in the presence of Mg or Ca ions PARP2 forms complexes with a nucleosome containing different number of PARP2 molecules without altering conformation of nucleosomal DNA. In contrast, Zn ions directly interact with PARP2 inducing a local alteration of the secondary structure of the protein and PARP2-mediated, reversible structural reorganization of nucleosomes. WGR domain of PARP2 is the target for Zn ions since this domain contains two putative Znbinding sites, binds Zn ions and alone drives Zn-mediated reorganization of nucleosomes. Auto(poly-ADP-ribosylation) activity of PARP2 is enhanced by Mg ions and modulated by Zn ions: suppressed or enhanced depending on the occupancy of two functionally different zinc binding sites. The data suggest that transient changes in concentration of cations can differentially modulate PARP2 activity, local chromatin structure and the DNA damage response.

摘要

聚(ADP - 核糖)聚合酶2(PARP2)是一种核蛋白、DNA损伤传感器,也是抗癌药物开发中一个新兴的靶点。此前已发现PARP2与核小体结合;然而,这一过程中涉及的关键因素仍不清楚。我们证明,在镁离子或钙离子存在的情况下,PARP2与含有不同数量PARP2分子的核小体形成复合物,而不会改变核小体DNA的构象。相比之下,锌离子直接与PARP2相互作用,导致蛋白质二级结构发生局部改变,并引发PARP2介导的核小体可逆结构重组。PARP2的WGR结构域是锌离子的作用靶点,因为该结构域包含两个假定的锌结合位点,能结合锌离子,并且单独就能驱动锌介导的核小体重组。PARP2的自身(聚ADP - 核糖基化)活性受到镁离子的增强作用,并受到锌离子的调节:根据两个功能不同的锌结合位点的占据情况,锌离子会抑制或增强PARP2的活性。这些数据表明,阳离子浓度的瞬时变化可以差异性地调节PARP2活性、局部染色质结构和DNA损伤反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/1e70c5ee2303/18_2025_5785_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/eaa92558a530/18_2025_5785_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/238b11c93437/18_2025_5785_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/5cc92731229c/18_2025_5785_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/a3dc8caf46db/18_2025_5785_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/1e70c5ee2303/18_2025_5785_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/eaa92558a530/18_2025_5785_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/238b11c93437/18_2025_5785_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/5cc92731229c/18_2025_5785_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/a3dc8caf46db/18_2025_5785_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd35/12209172/1e70c5ee2303/18_2025_5785_Fig5_HTML.jpg

相似文献

1
Poly(ADP-ribose)polymerase 2 is zinc-dependent enzyme and nucleosome reorganizer.聚(ADP-核糖)聚合酶2是一种锌依赖性酶和核小体重组器。
Cell Mol Life Sci. 2025 Jun 30;82(1):267. doi: 10.1007/s00018-025-05785-8.
2
Zinc-dependent Nucleosome Reorganization by PARP2.PARP2介导的锌离子依赖性核小体重组
bioRxiv. 2023 Oct 17:2023.10.17.562808. doi: 10.1101/2023.10.17.562808.
3
The dynamics and regulation of PARP1 and PARP2 in response to DNA damage and during replication.PARP1 和 PARP2 在应对 DNA 损伤和复制过程中的动态变化和调控。
DNA Repair (Amst). 2024 Aug;140:103690. doi: 10.1016/j.dnarep.2024.103690. Epub 2024 May 25.
4
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.聚(ADP-核糖)聚合酶(PARP)抑制剂治疗卵巢癌。
Cochrane Database Syst Rev. 2022 Feb 16;2(2):CD007929. doi: 10.1002/14651858.CD007929.pub4.
5
Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer.PARP1和PARP2拷贝数改变在前列腺癌中的预后价值
Lab Invest. 2025 Jun;105(6):104171. doi: 10.1016/j.labinv.2025.104171. Epub 2025 Apr 8.
6
Joining of DNA breaks- interplay between DNA ligases and poly (ADP-ribose) polymerases.DNA断裂的连接——DNA连接酶与聚(ADP-核糖)聚合酶之间的相互作用
DNA Repair (Amst). 2025 May;149:103843. doi: 10.1016/j.dnarep.2025.103843. Epub 2025 May 2.
7
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
8
Novel inhibitors of PARP1 and PARP14: design, synthesis, and potentiation of cisplatin efficacy in cancer.PARP1和PARP14的新型抑制剂:设计、合成及增强顺铂在癌症治疗中的疗效
Future Med Chem. 2025 Jan;17(1):35-58. doi: 10.1080/17568919.2024.2437972. Epub 2024 Dec 18.
9
The HPF1-dependent histone PARylation catalyzed by PARP2 is specifically stimulated by an incised AP site-containing BER DNA intermediate.PARP2 依赖性 HPF1 介导的组蛋白 PAR 化作用可被包含切口 AP 位点的 BER DNA 中间物特异性地激活。
DNA Repair (Amst). 2022 Dec;120:103423. doi: 10.1016/j.dnarep.2022.103423. Epub 2022 Oct 31.
10
PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.PARP 力量:PARP1、PARP2 和 PARP3 在 DNA 损伤修复和核小体重塑中的结构视角。
Int J Mol Sci. 2021 May 12;22(10):5112. doi: 10.3390/ijms22105112.

本文引用的文献

1
Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts.失活的 Parp2 通过阻断红细胞中复制相关的缺口连接,导致 Tp53 依赖性致死性贫血。
Mol Cell. 2024 Oct 17;84(20):3916-3931.e7. doi: 10.1016/j.molcel.2024.09.020. Epub 2024 Oct 8.
2
PARP Inhibitors for Breast Cancer Treatment: A Review.PARP 抑制剂在乳腺癌治疗中的应用:综述。
JAMA Oncol. 2024 May 1;10(5):658-670. doi: 10.1001/jamaoncol.2023.7322.
3
Role of zinc in health and disease.锌在健康与疾病中的作用。
Clin Exp Med. 2024 Feb 17;24(1):38. doi: 10.1007/s10238-024-01302-6.
4
Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis.PARP 抑制剂在携带有 BRCA 或 HRR 基因突变的转移性前列腺癌患者中的血液学毒性:系统评价和安全性荟萃分析。
Target Oncol. 2024 Jan;19(1):1-11. doi: 10.1007/s11523-023-01016-x. Epub 2023 Nov 22.
5
Clinical PARP inhibitors allosterically induce PARP2 retention on DNA.临床 PARP 抑制剂别构诱导 PARP2 在 DNA 上的滞留。
Sci Adv. 2023 Mar 24;9(12):eadf7175. doi: 10.1126/sciadv.adf7175.
6
Effect of oral magnesium supplement on cardiometabolic markers in people with prediabetes: a double blind randomized controlled clinical trial.口服镁补充剂对糖尿病前期人群心代谢标志物的影响:一项双盲随机对照临床试验。
Sci Rep. 2022 Oct 28;12(1):18209. doi: 10.1038/s41598-022-20277-6.
7
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper.AZD5305 的临床前特征:新一代高选择性 PARP1 抑制剂和捕获剂
Clin Cancer Res. 2022 Nov 1;28(21):4724-4736. doi: 10.1158/1078-0432.CCR-22-0301.
8
Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer.转移性去势抵抗性前列腺癌中PARP抑制剂的毒性综述
Clin Genitourin Cancer. 2023 Feb;21(1):183-193. doi: 10.1016/j.clgc.2022.07.005. Epub 2022 Jul 16.
9
Hematological toxicities in PARP inhibitors: A real-world study using FDA adverse event reporting system (FAERS) database.PARP 抑制剂的血液学毒性:使用 FDA 不良事件报告系统 (FAERS) 数据库的真实世界研究。
Cancer Med. 2023 Feb;12(3):3365-3375. doi: 10.1002/cam4.5062. Epub 2022 Jul 24.
10
BeStSel: webserver for secondary structure and fold prediction for protein CD spectroscopy.BeStSel:用于蛋白质圆二色光谱二级结构和折叠预测的网络服务器。
Nucleic Acids Res. 2022 Jul 5;50(W1):W90-W98. doi: 10.1093/nar/gkac345.